A Translational Systems Medicine Approach to Provide Predictive Capacity for Therapy Response in Advanced or Metastatic Malignant Melanoma

NCT02177110 · clinicaltrials.gov ↗

COMPLETED

Status

16

Enrollment

NETWORK

Sponsor class

Conditions

Advanced Melanoma
Metastatic Melanoma

Sponsor

Cancer Trials Ireland